Products
Insights
Products
Use Cases
Data
Platform
Getting Started
About PitchBook
Log in
Request a free trial
Use Cases
Explore what PitchBook can do for you
Market Intelligence
Follow capital flows across investors, deals, and industry trends
Deal Sourcing
Find investment opportunities and active investors faster
Deal Execution
Act on timely transactions to manage pipelines efficiently
Networking
Connect with the right decision-makers and advisors
Due Diligence
Validate investment decisions with verified company and financial data
Fundraising
Make your pitch stand out with LP commitment and mandate data
Benchmarking
Build private market benchmarks to understand fund performance
Business Development
Identify growth opportunities to strengthen your position
Asset Allocation
Optimize allocations and portfolio risk exposure
Portfolio Management
Reduce time to insight with AI-powered data extraction and tracking
Explore all use cases
Data
Discover comprehensive datasets
Companies
Uncover financial data on private and public companies
Investors
Explore investor track records and activity
Deals
Evaluate deal histories and multiples
Funds
Compare global fund performance data across strategies
Credit
Access timely lending and investment data
Debt
Identify debt and refinancing opportunities
Lenders
Identify lender activity and preferences
Limited Partners
Review LP commitments, mandates, and strategies
People
Find who to contact and how to connect
Service Providers
Find the right advisors to support your next move
Explore all data
Platform
Explore our full suite of technologies
Platform Overview
Access critical private market insights in one centralized hub
Desktop
Discover the go-to workflow hub for every investment stage
Mobile
Access insights and data on the go with the PitchBook Mobile app
Integrations
Work smarter with Excel, PowerPoint, and Chrome workflow tools
Direct Data
Connect our data to your systems with the PitchBook API and Data feed
CRM Integration
Integrate PitchBook’s data with your CRM
Lumonic
Monitor your private market portfolio with Lumonic
AI and ML Capabilities
Accelerate insights with our artificial intelligence and machine learning tools
Explore all platform
Getting Started
Discover the PitchBook difference
Take a Tour
Experience PitchBook firsthand with a guided platform preview
Profiles
Preview our company and investor data
Request a Free Trial
Request your free trial to access PitchBook and act confidently
How We Compare
Learn why PitchBook is the preferred choice
Pricing
Request PitchBook pricing options
Learning
Expand your knowledge with online courses and resources
Explore all
About PitchBook
Get to know PitchBook
Company
Learn how PitchBook is shaping the future of finance
Partnerships
Meet our partners and contact us for future collaborations
Webinars and Events
Learn more about our upcoming webinars and industry events
Press Center
Read recent and notable press mentions
Customer Stories
Read about how our clients succeed with PitchBook
Customer Success
Discover how we enable your success
Awards
Review PitchBook’s Global League Table Award winners
Careers
Learn more about working at PitchBook
Contact Us
Get in touch with our team
Explore all about
Insights
Latest
Research Library
Private Equity
Venture Capital
Credit
Industry & Tech
Allocators
Dashboards & Tools
Log in
Request a free trial
Latest
ㅤ
Latest News
News, analysis, and data shaping private markets
Latest Research
Data-driven private capital research from our experts
Dashboards & Tools
Interactive data assets for dealmakers and allocators
PitchBook-NVCA Venture Monitor
Data-driven overview of the trends defining US venture capital
US PE Breakdown
Definitive research on the forces shaping US private equity
EMEA & APAC
Private market trends in Europe, Asia-Pacific, and other regions
PitchBook Benchmarks
The latest data for closed-end fund returns across strategies
Indexes
A suite of indexes to track the convergence of public and private markets
Subscribe to Our Newsletters
VC, PE, M&A, and leveraged finance updates delivered to your inbox
Research Library
ㅤ
Private Equity
In-depth analysis of global PE markets, deals, and performance trends
Venture Capital
Comprehensive insights, from emerging startups to global deal activity
Credit
Insights on private credit, syndicated loans, CLOs, high-yield bonds, distressed debt, and more
Funds & Benchmarks
Private fund performance benchmarks, fundraising activity, and more
Europe
Private market coverage of Europe
Industry & Tech
Emerging tech research on AI, healthcare, energy, and more
Private Equity
ㅤ
Latest PE News
News, analysis, and data on private equity
Latest PE Research
Definitive research on key trends shaping private equity
Buyouts and M&A
Insights into deal flow, valuations, and market drivers
Private Credit
Developments and trends shaping private credit
Fundraising
Explore PE fundraising activity, from emerging funds to global giants
European PE
News and analysis of European private equity
PE Exits and Secondaries
PE-backed exits, IPOs, and GP-led secondaries
Subscribe to The Daily Pitch PE Newsletter
Get updates on PE news, deals, and analysis delivered to your inbox
Venture Capital
ㅤ
Latest VC News
News, analysis, and data shaping the venture capital industry
Latest VC Research
Expert analysis of trends defining the venture capital landscape
Artificial Intelligence
Track how AI is transforming industries and tech investment
European VC
Analysis of key trends shaping European venture capital
Exits & IPOs
Startup M&A, VC-backed IPOs, direct secondaries, and more
Valuations
Valuation trends and news for dealmakers
Fundraising
Insights into fundraising activity by venture firms
Subscribe to The Daily Pitch VC Newsletter
Stay ahead in the evolving world of VC, startups, and technology
Credit
ㅤ
Latest Credit News
Credit market activity, themes, and industry-shaping forces
LCD Research
Reports on leveraged loans, private credit, and high-yield bonds
Subscribe to The Credit Pitch Newsletter
Weekly coverage of US and European leveraged finance activity
Private Credit
Developments and trends shaping private credit
Syndicated Loans
News and analysis of leveraged loan issuance, pricing, and performance
Distressed Debt
Insights into distressed credit opportunities, restructurings, and more
Industry & Tech
ㅤ
Latest Industry & Tech News & Research
News, analysis, and data driving industry and technology investment
Artificial Intelligence
Track the latest trends driving AI investment
Healthcare
Monitor the latest PE and VC activity across the healthcare industry
Industrials
Follow PE and VC trends across key industrial segments
Software & Technology
Track PE and VC trends across the software and technology industry
Fintech
Monitor the latest fintech investment developments
Allocators
ㅤ
Latest Limited Partner News
News, analysis, and data on the world of allocators
Fund Performance & Benchmarks
Insights into private fund performance and benchmarks
Fundraising
Track fundraising activity from emerging funds to global giants
Secondaries
Secondary market analysis of GP-led transactions and LP stake sales
Sustainable Investing
Explore news, trends, and research related to sustainable investing
Allocator Solutions
Research and data to power LP workflows
Public-Private Convergence
The latest developments on the intersection of public and private markets
Subscribe to the Capital Pool Newsletter
Weekly commentary on what's driving LP decision-making
Dashboards & Tools
ㅤ
Latest Dashboards & Tools
Indicators, trackers and other tools for dealmakers and allocators
League Tables
Rankings of investors, managers, and lenders across asset classes
Search
Request a free trial
Log in
Biotech
More news about this topic
Commentary
Parabilis now the largest VC-backed biotech IPO
June 10, 2026
The stock jumped 58% in its first day of trading on the Nasdaq Global Select Market on Wednesday.
Article
Learn more »
Venture Capital
Some investors are turning to biotech as a hedge against potential AI bubbles
May 29, 2026
They’re betting that with the continuous need for health care, the sector is more immune.
Article
Learn more »
VC Exits
Biotech IPOs poised for a comeback—but only for some
April 15, 2026
A GLP-1 maker and a protein biomarker detection company are the latest to head for biotech IPOs. M&A activity is helping bolster that.
Article
Learn more »
Weekend Analysis
Why AI drug discovery isn’t the layup that VCs expected
January 9, 2026
Biotech investors have poured lots of cash into AI drug discovery bets. Will it pay off?
Article
Learn more »
VC Fundraising
Backing a crew of high-profile IPO hopefuls, Lux is poised for banner year
January 7, 2026
Lux closed on $1.5B for Fund IX, the deep-tech firm announced Wednesday
Article
Learn more »
Biotech
European VC biotech dealmaking rebounds to record highs
October 31, 2025
AI adoption, exit momentum and regulatory support have improved investor appetite.
Article
Learn more »
Weekend Analysis
As big pharma’s next patent cliff looms, biotech investors see dollar signs
September 12, 2025
Some $180 billion in pharma revenue is going off patent in 2027 and 2028.
Article
Learn more »
Biotech
The US posted zero biopharma IPOs in Q2. That hasn’t happened since 2016
August 15, 2025
Poor stock performance and elevated interest rates are keeping investors at bay.
Article
Learn more »
Biotech
With lenders galore, life science companies find debt cheaper
July 2, 2025
Lenders cut spreads and eased covenants for borrowers amid increased competition from other debt providers and pressure to deploy capital.
Article
Learn more »
Biotech
VCs have almost completely abandoned biotech investing
June 4, 2025
VC fundraising by firms with biotech strategies hasn’t been this slow since 2013
Article
Learn more »
Analyst Note
PitchBook Analyst Note: The Evolution of Biotech VC Funds
May 28, 2025
This analysis provides investors and fund managers with a data-driven view of biotech VC performance and structural trends.
Research
Learn more »
Biotech
Federal funding cuts could destroy the lab-grown unicorn
April 2, 2025
In 2023, federal sources accounted for more than half of the total $108 billion that U.S. academic institutions spent on R&D. Much of that spending is at risk.
Article
Learn more »
Biotech
Verdiva Bio joins weight loss race with $411M Series A
January 9, 2025
The London-based company’s launch coincides with a sharp increase of VC funding for weight loss companies.
Article
Learn more »
Private Equity
RFK Jr. nomination dents PE confidence in CRO market
December 12, 2024
Vaccine scrutiny could raise clinical trial standards, which poses a risk to fund managers with significant investments in CROs.
Article
Learn more »
Healthcare
Pharma services dealmaking nears quarterly record
November 18, 2024
PE deal activity in the sector is riding tailwinds from M&A-friendly interest rate policies and GPs’ growing appetite for life sciences investments.
Article
Learn more »
Biotech
Has PE fallen out of love with Europe’s biotech industry?
September 26, 2024
Data from the last five years shows that investment in biotech is dropping sharply with no signs of recovery.
Article
Learn more »
Biopharma
Candid Therapeutics launches with $370M and a pair of acquisitions
September 9, 2024
The startup focuses on repurposing cancer treatments for hard-to-treat autoimmune disorders.
Article
Learn more »
Top Investor
Biotech’s top 10 most active VC investors
September 4, 2024
The nascent application of AI in biotech and drug discovery is helping fuel a surge in valuations of venture-backed biopharma startups.
Article
Learn more »
